Wegovy dosage chart from the FDA label

The Wegovy injection starts at 0.25 mg once a week and steps up every 4 weeks, through 0.5 mg, 1 mg and 1.7 mg, to a maintenance dose from week 17. The recommended maintenance dose is 2.4 mg.1 This page reports the label, for the injection and the tablets. It does not tell you what to take.

Wegovy injection dosage chart

Wegovy injection, once weekly: the label's schedule for adults and for patients aged 12 and older.
WeeksWeekly doseStage
1 to 40.25 mgStarting dose
5 to 80.5 mgEscalation
9 to 121 mgEscalation
13 to 161.7 mgEscalation
17 onward2.4 mg (recommended) or 1.7 mgMaintenance

Source: section 2 of the label.1 If a dose is not tolerated during escalation, the label says to consider delaying the next increase by 4 weeks.1

Maintenance dose by use

UseMaintenance dose on the label
Weight reduction, adults2.4 mg (recommended) or 1.7 mg weekly. May go to a maximum of 7.2 mg weekly in some cases
Weight reduction, ages 12 and older2.4 mg (recommended) or 1.7 mg weekly
Lowering cardiovascular risk, adults2.4 mg (recommended) or 1.7 mg weekly
MASH, adults2.4 mg weekly. If not tolerated, 1.7 mg

Source: sections 1 and 2 of the label.1

Wegovy HD 7.2 mg

The label allows an increase to 7.2 mg weekly only for adults using Wegovy for weight reduction, only after tolerating 2.4 mg for at least 4 weeks, and only if more weight reduction is clinically indicated. 7.2 mg is the maximum.1

Wegovy tablets dosage chart

Wegovy tablets, once daily: the label's schedule for adults.
DaysDaily dose
1 to 301.5 mg
31 to 604 mg
61 to 909 mg
91 onward25 mg (maintenance)

The label says to take one tablet each morning on an empty stomach, with no more than 4 ounces of plain water, and to wait at least 30 minutes before eating, drinking or taking other oral medicines. Tablets are swallowed whole.1 The label says the tablets' safety and effectiveness have not been established in children.1

What is in the pens

From section 3 of the label.
PenStrengthWhat it delivers
Single-dose pen0.25, 0.5 or 1 mgOne dose in 0.5 mL
Single-dose pen1.7 or 2.4 mgOne dose in 0.75 mL
Single-dose pen (Wegovy HD)7.2 mgOne dose in 0.75 mL
FlexTouch pen9.6 mg / 3 mLFour 2.4 mg doses

The label also lists single-dose syringes up to 2.4 mg.1 These all deliver set doses in milligrams, so there are no syringe units to work out. If you have semaglutide in a vial instead, see the semaglutide dosage chart.

Missed doses

  • Injection, next dose more than 2 days away: take the missed dose as soon as possible.1
  • Injection, next dose less than 2 days away: skip it and take the next dose on the usual day.1
  • Two or more injections missed in a row: the label says to restart the escalation at a lower dose. That is a decision for your prescriber.1
  • Tablets: skip the missed dose and take the next one the following day.1

How the label says to inject

  • Once a week, on the same day each week, at any time of day, with or without meals.1
  • Under the skin of the abdomen, thigh or upper arm, changing the spot with each dose.1
  • Use it only if the liquid is clear, colorless and free of particles.1
  • Never share a FlexTouch pen with another person, even with a new needle.1

Storage

  • Single-dose pens and syringes: in the refrigerator at 2°C to 8°C (36°F to 46°F), in the original carton, away from light. A pen can be kept at 8°C to 30°C (46°F to 86°F) for up to 28 days before the cap is removed. Do not freeze.1
  • FlexTouch pen: in the refrigerator before first use. After first use, up to 56 days at 15°C to 30°C (59°F to 86°F) or in the refrigerator, with the cap on and no needle attached.1
  • Tablets: at room temperature, 20°C to 25°C (68°F to 77°F), in the original bottle, away from moisture.1

Side effects and warnings on the label

The most common side effects listed include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness and hair loss. In adults on the 2.4 mg injection, 44% reported nausea, against 16% on placebo.1

The label carries a boxed warning about thyroid C-cell tumors, which semaglutide causes in rodents; whether it does so in humans is unknown. Wegovy is contraindicated for people with a personal or family history of medullary thyroid carcinoma or with MEN 2, and for people who have had a serious allergic reaction to semaglutide.1 The label does not recommend using it with other semaglutide products or any other GLP-1 receptor agonist.1 This is not the full safety information. Read the Medication Guide that comes with your prescription.

Related

See the Ozempic dosage chart, or Ozempic and Wegovy side by side. See also Ozempic vs Wegovy.

Questions

What is the starting dose of Wegovy?

For the injection, the label gives 0.25 mg once a week for weeks 1 to 4. For the tablets, it gives 1.5 mg once a day for days 1 to 30.

What is the maintenance dose of Wegovy?

For the injection, the label lists 2.4 mg once a week as recommended, or 1.7 mg. For the tablets, it lists 25 mg once a day.

What is Wegovy HD?

A 7.2 mg single-dose pen. The label allows adults using Wegovy for weight reduction to increase to a maximum of 7.2 mg weekly, after tolerating 2.4 mg for at least 4 weeks, if more weight reduction is clinically indicated.

How long does it take to reach the full dose of Wegovy?

On the label schedule, the maintenance dose of the injection starts at week 17. For the tablets, it starts at day 91.

What if I miss a dose of Wegovy?

For the injection, the label says to take it as soon as possible if your next dose is more than 2 days away, and to skip it if the next dose is less than 2 days away. For the tablets, skip it and take the next one the following day.

What if I miss two Wegovy injections in a row?

The label says to restart the escalation at a lower dose. That is a decision for your prescriber.

Can a step be delayed?

The label says to consider delaying the next increase by 4 weeks if a dose is not tolerated.

How long can a Wegovy pen stay out of the fridge?

The label says a single-dose pen can be kept at 8°C to 30°C (46°F to 86°F) for up to 28 days before the cap is removed.

Who is Wegovy approved for?

The injection is approved for weight reduction in adults and in patients aged 12 and older, for lowering cardiovascular risk in certain adults, and for MASH in adults. The tablets are approved for adults only.

Sources

  1. Novo Nordisk. Wegovy (semaglutide) injection and tablets prescribing information, revised 06/2026, as posted by the FDA. accessdata.fda.gov (PDF) (opens in a new tab)
  2. Formulas and test cases: how the calculator math works.